Probiotics: Potential Benefits and Safety in Hematological Malignancies

Probiotics in Hematologic Cancers

Authors

  • Mahdiyar Iravani Saadi Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
  • Mani Ramzi 1-Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran/ 2-Hematology, Oncology and Bone Marrow Transplantation Department, Shiraz University of Medical Sciences, Shiraz, Iran
  • Nastaran Fooladivanda Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
  • Sholeh Afshinpour Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
  • Zahra Ghahramani Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
  • Maryam Ahmadyan Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
  • Nadiya Kheradmand Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
  • Nadiya Kheradmand Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
  • Hourvash Haghighinejad Family Medicine Department, Shiraz University of Medical Sciences, Shiraz, Iran
  • Zahra Rahimian Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

Keywords:

Probiotics; Hematologic Malignancy; Chemotherapy; Radiation Therapy; Hematopoietic Stem Cell Transplantation; HSCT; GVHD

Abstract

Cancer remains one of the most significant global health challenges, with increasing incidence and mortality rates and a substantial socioeconomic burden. Traditional cancer treatments such as chemotherapeutic drugs and radiation therapies, while effective, have significant adverse effects on the body, prompting the search for less invasive treatment options. In recent years, probiotics have emerged as a promising alternative in the prevention and treatment of cancer and its associated complications, especially in gastrointestinal malignancies. Probiotics have been found to have several beneficial effects on the body, including the ability to mitigate the gastrointestinal side effects of cancer treatments by restoring gut microbiota balance and improving intestinal barrier function. By reducing inflammation and enhancing the immune response, probiotics can also help alleviate other cancer-related symptoms and improve the overall well-being of cancer patients. Despite their potential benefits, the efficacy and safety of probiotics in immunocompromised patients remain uncertain, and caution must be exercised during their administration. Further research is needed to determine the optimal clinical use, safety, and efficacy of probiotics in cancer treatment.

References

Mattiuzzi C, Lippi G. Current cancer epidemiology. J Epidemiol Glob Health. 2019;9(4):217-22.

https://doi.org/10.2991/jegh.k.191008.001

PMid:31854162 PMCid:PMC7310786

Chen L, Zheng Y, Yu K, Chen S, Wang W, Gale RP, et al. Changing causes of death in persons with haematological cancers 1975-2016. Leukemia. 2022;36(7):1850-60.

https://doi.org/10.1038/s41375-022-01596-z

PMid:35577905 PMCid:PMC9252904

Roman E, Smith A, Appleton S, Crouch S, Kelly R, Kinsey S, et al. Myeloid malignancies in the real-world: Occurrence, progression and survival in the UK's population-based Haematological Malignancy Research Network 2004-15. Cancer Epidemiol. 2016;42:186-98.

https://doi.org/10.1016/j.canep.2016.03.011

PMid:27090942 PMCid:PMC4911595

Pearce A, Haas M, Viney R, Pearson S-A, Haywood P, Brown C, et al. Incidence and severity of self-reported chemotherapy side effects in routine care: A prospective cohort study. PLoS One. 2017;12(10):e0184360.

https://doi.org/10.1371/journal.pone.0184360

PMid:29016607 PMCid:PMC5634543

Schirrmacher V. From chemotherapy to biological therapy: A review of novel concepts to reduce the side effects of systemic cancer treatment (Review). Int J Oncol. 2019;54(2):407-19.

https://doi.org/10.3892/ijo.2018.4661

PMid:30570109 PMCid:PMC6317661

Baudino TA. Targeted cancer therapy: the next generation of cancer treatment. Curr Drug Discov Technol. 2015;12(1):3-20.

https://doi.org/10.2174/1570163812666150602144310

PMid:26033233

Reis Ferreira M, Andreyev HJN, Mohammed K, Truelove L, Gowan SM, Li J, et al. Microbiota- and Radiotherapy-Induced Gastrointestinal Side-Effects (MARS) Study: A Large Pilot Study of the Microbiome in Acute and Late-Radiation Enteropathy. Clin Cancer Res. 2019;25(21):6487-500.

https://doi.org/10.1158/1078-0432.CCR-19-0960

PMid:31345839

Elliott SP, Malaeb BS. Long-term urinary adverse effects of pelvic radiotherapy. World J Urol. 2011;29(1):35-41.

https://doi.org/10.1007/s00345-010-0603-x

PMid:20959990 PMCid:PMC3075494

Fattizzo B, Cavallaro F, Folino F, Barcellini W. Recent insights into the role of the microbiome in malignant and benign hematologic diseases. Crit Rev Oncol Hematol. 2021;160:103289.

https://doi.org/10.1016/j.critrevonc.2021.103289

PMid:33667659

Hong B-Y, Sobue T, Choquette L, Dupuy AK, Thompson A, Burleson JA, et al. Chemotherapy-induced oral mucositis is associated with detrimental bacterial dysbiosis. Microbiome. 2019;7(1):66.

https://doi.org/10.1186/s40168-019-0679-5

PMid:31018870 PMCid:PMC6482518

Rashidi A, Kaiser T, Graiziger C, Holtan SG, Rehman TU, Weisdorf DJ, et al. Gut dysbiosis during antileukemia chemotherapy versus allogeneic hematopoietic cell transplantation. Cancer. 2020;126(7):1434-47.

https://doi.org/10.1002/cncr.32641

PMid:31873965

Montassier E, Gastinne T, Vangay P, Al-Ghalith GA, Bruley des Varannes S, Massart S, et al. Chemotherapy-driven dysbiosis in the intestinal microbiome. Aliment Pharmacol Ther. 2015;42(5):515-28.

https://doi.org/10.1111/apt.13302

PMid:26147207

Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7-34.

https://doi.org/10.3322/caac.21551

PMid:30620402

Górska A, Przystupski D, Niemczura MJ, Kulbacka J. Probiotic bacteria: A promising tool in cancer prevention and therapy. Curr Microbiol. 2019;76(8):939-49.

https://doi.org/10.1007/s00284-019-01679-8

PMid:30949803 PMCid:PMC6586914

Sharifi M, Moridnia A, Mortazavi D, Salehi M, Bagheri M, Sheikhi A. Kefir: a powerful probiotics with anticancer properties. Med Oncol. 2017;34(11):183.

https://doi.org/10.1007/s12032-017-1044-9

PMid:28956261

Pop OL, Suharoschi R, Gabbianelli R. Biodetoxification and Protective Properties of Probiotics. Microorganisms. 2022;10(7):1278.

https://doi.org/10.3390/microorganisms10071278

PMid:35888997 PMCid:PMC9319832

Sanders ME, Merenstein DJ, Reid G, Gibson GR, Rastall RA. Probiotics and prebiotics in intestinal health and disease: from biology to the clinic. Nat Rev Gastroenterol Hepatol. 2019;16(10):605-16.

https://doi.org/10.1038/s41575-019-0173-3

PMid:31296969

Hrdý J, Alard J, Couturier-Maillard A, Boulard O, Boutillier D, Delacre M, et al. Lactobacillus reuteri 5454 and Bifidobacterium animalis ssp lactis 5764 improve colitis while differentially impacting dendritic cells maturation and antimicrobial responses. Sci Rep. 2020;10(1):5345.

https://doi.org/10.1038/s41598-020-62161-1

PMid:32210304 PMCid:PMC7093418

Kim SK, Guevarra RB, Kim YT, Kwon J, Kim H, Cho JH, et al. Role of probiotics in human gut microbiome-associated diseases. J Microbiol Biotechnol. 2019;29(9):1335-40.

https://doi.org/10.4014/jmb.1906.06064

PMid:31434172

Sotoudegan F, Daniali M, Hassani S, Nikfar S, Abdollahi M. Reappraisal of probiotics' safety in human. Food Chem Toxicol. 2019;129:22-9.

https://doi.org/10.1016/j.fct.2019.04.032

PMid:31009735

Sender R, Fuchs S, Milo R. Are we really vastly outnumbered Revisiting the ratio of bacterial to host cells in humans. Cell. 2016;164(3):337-40.

https://doi.org/10.1016/j.cell.2016.01.013

PMid:26824647

Tierney BT, Yang Z, Luber JM, Beaudin M, Wibowo MC, Baek C, et al. The Landscape of Genetic Content in the Gut and Oral Human Microbiome. Cell Host Microbe. 2019;26(2):283-95 e8.

https://doi.org/10.1016/j.chom.2019.07.008

PMid:31415755 PMCid:PMC6716383

Zou S, Fang L, Lee M-H. Dysbiosis of gut microbiota in promoting the development of colorectal cancer. Gastroenterology Report. 2017;6(1):1-12.

https://doi.org/10.1093/gastro/gox031

PMid:29479437 PMCid:PMC5806407

Slizewska K, Markowiak-Kopec P, Slizewska W. The role of probiotics in cancer prevention. Cancers (Basel). 2020;13(1):20.

https://doi.org/10.3390/cancers13010020

PMid:33374549 PMCid:PMC7793079

Sanchez B, Delgado S, Blanco-Miguez A, Lourenco A, Gueimonde M, Margolles A. Probiotics, gut microbiota, and their influence on host health and disease. Mol Nutr Food Res. 2017;61(1):1600240.

https://doi.org/10.1002/mnfr.201600240

PMid:27500859

Hamasalim HJ. Synbiotic as feed additives relating to animal health and performance. Adv Microbiol. 2016;6(4):288-302.

https://doi.org/10.4236/aim.2016.64028

Smith PM, Howitt MR, Panikov N, Michaud M, Gallini CA, Bohlooly YM, et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science. 2013;341(6145):569-73.

https://doi.org/10.1126/science.1241165

PMid:23828891 PMCid:PMC3807819

Chen J, Vitetta L. Inflammation-modulating effect of butyrate in the prevention of colon cancer by dietary fiber. Clin Colorectal Cancer. 2018;17(3):e541-e4.

https://doi.org/10.1016/j.clcc.2018.05.001

PMid:29866614

Ding S, Yan W, Ma Y, Fang J. The impact of probiotics on gut health via alternation of immune status of monogastric animals. Animal Nutrition. 2021;7(1):24-30.

https://doi.org/10.1016/j.aninu.2020.11.004

PMid:33997328 PMCid:PMC8110871

Evrard B, Coudeyras S, Dosgilbert A, Charbonnel N, Alame J, Tridon A, et al. Dose-dependent immunomodulation of human dendritic cells by the probiotic Lactobacillus rhamnosus Lcr35. PLoS One. 2011;6(4):e18735.

https://doi.org/10.1371/journal.pone.0018735

PMid:21533162 PMCid:PMC3078917

Mohammed AT, Khattab M, Ahmed AM, Turk T, Sakr N, A MK, et al. The therapeutic effect of probiotics on rheumatoid arthritis: a systematic review and meta-analysis of randomized control trials. Clin Rheumatol. 2017;36(12):2697-707.

https://doi.org/10.1007/s10067-017-3814-3

PMid:28914373

Plaza-Díaz J, Ruiz-Ojeda FJ, Vilchez-Padial LM, Gil A. Evidence of the Anti-Inflammatory Effects of Probiotics and Synbiotics in Intestinal Chronic Diseases. Nutrients. 2017;9(6):555.

https://doi.org/10.3390/nu9060555

PMid:28555037 PMCid:PMC5490534

Yousefi B, Eslami M, Ghasemian A, Kokhaei P, Salek Farrokhi A, Darabi N. Probiotics importance and their immunomodulatory properties. J Cell Physiol. 2019;234(6):8008-18.

https://doi.org/10.1002/jcp.27559

PMid:30317594

Zhou A, Yuan Y, Yang M, Huang Y, Li X, Li S, et al. Crosstalk between the gut microbiota and epithelial cells under physiological and infectious conditions. Front Cell Infect Microbiol. 2022;12:832672.

https://doi.org/10.3389/fcimb.2022.832672

PMid:35155283 PMCid:PMC8829037

Wang C, Li Q, Ren J. Microbiota-Immune Interaction in the Pathogenesis of Gut-Derived Infection. Front Immunol. 2019;10:1873.

https://doi.org/10.3389/fimmu.2019.01873

PMid:31456801 PMCid:PMC6698791

Lemme-Dumit JM, Polti MA, Perdigon G, Galdeano CM. Probiotic bacteria cell walls stimulate the activity of the intestinal epithelial cells and macrophage functionality. Benef Microbes. 2018;9(1):153-64.

https://doi.org/10.3920/BM2016.0220

PMid:29124968

Maldonado Galdeano C, Cazorla SI, Lemme Dumit JM, Vélez E, Perdigón G. Beneficial Effects of Probiotic Consumption on the Immune System. Annals of nutrition & metabolism. 2019;74(2):115-24.

https://doi.org/10.1159/000496426

PMid:30673668

Rizzello V, Bonaccorsi I, Dongarra ML, Fink LN, Ferlazzo G. Role of natural killer and dendritic cell crosstalk in immunomodulation by commensal bacteria probiotics. J Biomed Biotechnol. 2011;2011:473097.

https://doi.org/10.1155/2011/473097

PMid:21660136 PMCid:PMC3110311

Lin W-Y, Kuo Y-W, Chen C-W, Huang Y-F, Hsu C-H, Lin J-H, et al. Viable and Heat-Killed Probiotic Strains Improve Oral Immunity by Elevating the IgA Concentration in the Oral Mucosa. Curr Microbiol. 2021;78(9):3541-9.

https://doi.org/10.1007/s00284-021-02569-8

PMid:34345965 PMCid:PMC8363536

DeGruttola AK, Low D, Mizoguchi A, Mizoguchi E. Current understanding of dysbiosis in disease in human and animal models. Inflamm Bowel Dis. 2016;22(5):1137-50.

https://doi.org/10.1097/MIB.0000000000000750

PMid:27070911 PMCid:PMC4838534

Goodman B, Gardner H. The microbiome and cancer. J Pathol. 2018;244(5):667-76.

https://doi.org/10.1002/path.5047

PMid:29377130

Noroozi E, Tebianian M, Taghizadeh M, Dadar M, Mojgani N. Anticarcinogenic potential of probiotic, postbiotic metabolites and paraprobiotics on human cancer cells. In: Mojgani N, Dadar M, editors. Probiotic Bacteria and Postbiotic Metabolites: Role in Animal and Human Health. Microorganisms for Sustainability. Singapore: Springer Singapore; 2021. p. 153-77.

https://doi.org/10.1007/978-981-16-0223-8_6

Weill FS, Cela EM, Paz ML, Ferrari A, Leoni J, Maglio DHG. Lipoteichoic acid from Lactobacillus rhamnosus GG as an oral photoprotective agent against UV-induced carcinogenesis. Br J Nutr. 2013;109(3):457-66.

https://doi.org/10.1017/S0007114512001225

PMid:22874095

Maalouf K, Baydoun E, Rizk S. Kefir induces cell-cycle arrest and apoptosis in HTLV-1-negative malignant T-lymphocytes. Cancer Manag Res. 2011;3:39-47.

https://doi.org/10.2147/CMR.S15109

PMid:21448298 PMCid:PMC3064404

Jalali F, Sharifi M, Salehi R. Kefir induces apoptosis and inhibits cell proliferation in human acute erythroleukemia. Med Oncol. 2016;33(1):7.

https://doi.org/10.1007/s12032-015-0722-8

PMid:26708130

Chiu YH, Hsieh YJ, Liao KW, Peng KC. Preferential promotion of apoptosis of monocytes by Lactobacillus casei rhamnosus soluble factors. Clin Nutr. 2010;29(1):131-40.

https://doi.org/10.1016/j.clnu.2009.07.004

PMid:19665262

Calcinotto A, Brevi A, Chesi M, Ferrarese R, Garcia Perez L, Grioni M, et al. Microbiota-driven interleukin-17-producing cells and eosinophils synergize to accelerate multiple myeloma progression. Nat Commun. 2018;9(1):4832.

https://doi.org/10.1038/s41467-018-07305-8

PMid:30510245 PMCid:PMC6277390

Pianko MJ, Golob JL. Host-microbe interactions and outcomes in multiple myeloma and hematopoietic stem cell transplantation. Cancer Metastasis Rev. 2022;41(2):367-82.

https://doi.org/10.1007/s10555-022-10033-7

PMid:35488106 PMCid:PMC9378527

Salas C, Niembro A, Lozano V, Gallardo E, Molina B, Sanchez S, et al. Persistent genomic instability in peripheral blood lymphocytes from Hodgkin lymphoma survivors. Environ Mol Mutagen. 2012;53(4):271-80.

https://doi.org/10.1002/em.21691

PMid:22434555

Cozen W, Yu G, Gail MH, Ridaura VK, Nathwani BN, Hwang AE, et al. Fecal microbiota diversity in survivors of adolescent/young adult Hodgkin lymphoma: a study of twins. Br J Cancer. 2013;108(5):1163-7.

https://doi.org/10.1038/bjc.2013.60

PMid:23443674 PMCid:PMC3619077

Greaves P, Clear A, Owen A, Iqbal S, Lee A, Matthews J, et al. Defining characteristics of classical Hodgkin lymphoma microenvironment T-helper cells. Blood. 2013;122(16):2856-63.

https://doi.org/10.1182/blood-2013-06-508044

PMid:24004665 PMCid:PMC5291299

Ghoneum M, Gimzewski J. Apoptotic effect of a novel kefir product, PFT, on multidrug-resistant myeloid leukemia cells via a hole-piercing mechanism. Int J Oncol. 2014;44(3):830-7.

https://doi.org/10.3892/ijo.2014.2258

PMid:24430613 PMCid:PMC3928472

Pflug N, Kluth S, Vehreschild JJ, Bahlo J, Tacke D, Biehl L, et al. Efficacy of antineoplastic treatment is associated with the use of antibiotics that modulate intestinal microbiota. Oncoimmunology. 2016;5(6):e1150399.

https://doi.org/10.1080/2162402X.2016.1150399

PMid:27471619 PMCid:PMC4938364

Rafei H, Jenq RR. Microbiome-intestine cross talk during acute graft-versus-host disease. Blood. 2020;136(4):401-9.

https://doi.org/10.1182/blood.2019000950

PMid:32526029 PMCid:PMC7378453

Le Bastard Q, Chevallier P, Montassier E. Gut microbiome in allogeneic hematopoietic stem cell transplantation and specific changes associated with acute graft vs host disease. World J Gastroenterol. 2021;27(45):7792-800.

https://doi.org/10.3748/wjg.v27.i45.7792

PMid:34963742 PMCid:PMC8661383

Li J, Zhang X, Chen Y, Zheng Q, Zhao M, Jiang H. A promising insight: the potential influence and therapeutic value of the gut microbiota in GI GVHD. Oxid Med Cell Longev. 2022;2022:2124627.

https://doi.org/10.1155/2022/2124627

PMid:35571252 PMCid:PMC9098338

Pirozzolo I, Li Z, Sepulveda M, Alegre ML. Influence of the microbiome on solid organ transplant survival. J Heart Lung Transplant. 2021;40(8):745-53.

https://doi.org/10.1016/j.healun.2021.04.004

PMid:34030971 PMCid:PMC8319047

Gałązka P, Styczyński J, Czyżewski K, Salamonowicz-Bodzioch M, Frączkiewicz J, Zając-Spychała O, et al. Impact of decontamination therapy on gastrointestinal acute graft-versus-host disease after allogeneic hematopoietic cell transplantation in children: Decontamination therapy in allo-HCT. Curr Res Transl Med. 2021;69(3):103298.

https://doi.org/10.1016/j.retram.2021.103298

PMid:34144374

Biagi E, Zama D, Nastasi C, Consolandi C, Fiori J, Rampelli S, et al. Gut microbiota trajectory in pediatric patients undergoing hematopoietic SCT. Bone Marrow Transplant. 2015;50(7):992-8.

https://doi.org/10.1038/bmt.2015.16

PMid:25893458

Simms-Waldrip TR, Sunkersett G, Coughlin LA, Savani MR, Arana C, Kim J, et al. Antibiotic-induced depletion of anti-inflammatory clostridia is associated with the development of graft-versus-host disease in pediatric stem cell transplantation patients. Biol Blood Marrow Transplant. 2017;23(5):820-9.

https://doi.org/10.1016/j.bbmt.2017.02.004

PMid:28192251

Iravani-Saadi M, Karimi MH, Yaghobi R, Geramizadeh B, Ramzi M, Niknam A, et al. Polymorphism of costimulatory molecules (CTLA4, ICOS, PD.1 and CD28) and allogeneic hematopoietic stem cell transplantation in Iranian patients. Immunol Invest. 2014;43(4):391-404.

https://doi.org/10.3109/08820139.2013.879594

PMid:24564845

Biagi E, Zama D, Rampelli S, Turroni S, Brigidi P, Consolandi C, et al. Early gut microbiota signature of aGvHD in children given allogeneic hematopoietic cell transplantation for hematological disorders. BMC Med Genomics. 2019;12(1):49.

https://doi.org/10.1186/s12920-019-0494-7

PMid:30845942 PMCid:PMC6404274

Khuat LT, Dave M, Murphy WJ. The emerging roles of the gut microbiome in allogeneic hematopoietic stem cell transplantation. Gut Microbes. 2021;13(1):1966262.

https://doi.org/10.1080/19490976.2021.1966262

PMid:34455917 PMCid:PMC8436969

Rodriguez-Arrastia M, Martinez-Ortigosa A, Rueda-Ruzafa L, Folch Ayora A, Ropero-Padilla C. Probiotic supplements on oncology patients' treatment-related side effects: a systematic review of randomized controlled trials. Int J Environ Res Public Health. 2021;18(8):4265.

https://doi.org/10.3390/ijerph18084265

PMid:33920572 PMCid:PMC8074215

Fernandes A, Oliveira A, Soares R, Barata P. The effects of ionizing radiation on gut microbiota, a systematic review. Nutrients. 2021;13(9):3025.

https://doi.org/10.3390/nu13093025

PMid:34578902 PMCid:PMC8465723

Ali H, Khurana S, Ma W, Peng Y, Jiang ZD, DuPont H, et al. Safety and efficacy of fecal microbiota transplantation to treat and prevent recurrent Clostridioides difficile in cancer patients. J Cancer. 2021;12(21):6498-506.

https://doi.org/10.7150/jca.59251

PMid:34659541 PMCid:PMC8489149

Koyama S, Fujita H, Shimosato T, Kamijo A, Ishiyama Y, Yamamoto E, et al. Septicemia from Lactobacillus rhamnosus GG, from a probiotic enriched yogurt, in a patient with autologous stem cell transplantation. Probiotics Antimicrob Proteins. 2019;11(1):295-8.

https://doi.org/10.1007/s12602-018-9399-6

PMid:29455334

Avcin SL, Pokorn M, Kitanovski L, Premru MM, Jazbec J. Bifidobacterium breve Sepsis in Child with High-Risk Acute Lymphoblastic Leukemia. Emerg Infect Dis. 2015;21(9):1674-5.

https://doi.org/10.3201/eid2109.150097

PMid:26291071 PMCid:PMC4550169

Gilliam CH, Brazelton de Cardenas J, Carias D, Maron Alfaro G, Hayden RT, Hakim H. Lactobacillus bloodstream infections genetically related to probiotic use in pediatric hematopoietic cell transplant patients. Infect Control Hosp Epidemiol. 2023;44(3):484-7.

https://doi.org/10.1017/ice.2021.515

PMid:35225182

Kullar R, Goldstein EJC, Johnson S, McFarland LV. Lactobacillus Bacteremia and Probiotics: A Review. Microorganisms. 2023;11(4):896.

https://doi.org/10.3390/microorganisms11040896

PMid:37110319 PMCid:PMC10145752

Ambesh P, Stroud S, Franzova E, Gotesman J, Sharma K, Wolf L, et al. Recurrent Lactobacillus Bacteremia in a Patient With Leukemia. Journal of Investigative Medicine High Impact Case Reports. 2017;5(4):2324709617744233.

https://doi.org/10.1177/2324709617744233

PMid:29204452 PMCid:PMC5703097

Costa RL, Moreira J, Lorenzo A, Lamas CC. Infectious complications following probiotic ingestion: a potentially underestimated problem A systematic review of reports and case series. BMC Complement Altern Med. 2018;18(1):329.

https://doi.org/10.1186/s12906-018-2394-3

PMid:30541524 PMCid:PMC6292120

Lo C-H, Wu D-C, Jao S-W, Wu C-C, Lin C-Y, Chuang C-H, et al. Enrichment of Prevotella intermedia in human colorectal cancer and its additive effects with Fusobacterium nucleatum on the malignant transformation of colorectal adenomas. J Biomed Sci. 2022;29(1):88.

https://doi.org/10.1186/s12929-022-00869-0

PMid:36303164 PMCid:PMC9615364

Torp AM, Bahl MI, Boisen A, Licht TR. Optimizing oral delivery of next generation probiotics. Trends in Food Science & Technology. 2022;119:101-9.

https://doi.org/10.1016/j.tifs.2021.11.034

Roobab U, Batool Z, Manzoor MF, Shabbir MA, Khan MR, Aadil RM. Sources, formulations, advanced delivery and health benefits of probiotics. Current Opinion in Food Science. 2020;32:17-28.

https://doi.org/10.1016/j.cofs.2020.01.003

Baral KC, Bajracharya R, Lee SH, Han H-K. Advancements in the Pharmaceutical Applications of Probiotics: Dosage Forms and Formulation Technology. International Journal of Nanomedicine. 2021;16(null):7535-56.

https://doi.org/10.2147/IJN.S337427

PMid:34795482 PMCid:PMC8594788

Ouwehand A. A review of dose-responses of probiotics in human studies. Beneficial Microbes. 2017;8(2):143-51.

https://doi.org/10.3920/BM2016.0140

PMid:28008787

Shi L, Sheng J, Wang M, Luo H, Zhu J, Zhang B, et al. Combination Therapy of TGF-β Blockade and Commensal-derived Probiotics Provides Enhanced Antitumor Immune Response and Tumor Suppression. Theranostics. 2019;9(14):4115-29.

https://doi.org/10.7150/thno.35131

PMid:31281535 PMCid:PMC6592171

Palumbo VD, Romeo M, Marino Gammazza A, Carini F, Damiani P, Damiano G, et al. The long-term effects of probiotics in the therapy of ulcerative colitis: A clinical study. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2016;160(3):372-7.

https://doi.org/10.5507/bp.2016.044

PMid:27623957

Kong X-J, Liu J, Liu K, Koh M, Sherman H, Liu S, et al. Probiotic and oxytocin combination therapy in patients with autism spectrum disorder: a randomized, double-blinded, placebo-controlled pilot trial. Nutrients. 2021;13(5):1552.

https://doi.org/10.3390/nu13051552

PMid:34062986 PMCid:PMC8147925

Downloads

Published

2024-03-16

Issue

Vol. 13 (2024): 2024: In Progress

Section

Original Article

License

Copyright (c) 2024 Galen Medical Journal

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

https://creativecommons.org/licenses/by/4.0/